Coronavirus Update: Japan Approves Lagevrio, Korea Clears Paxlovid
Plus, Boosters In Japan, Further Vaccine Progress In Korea
Oral antivirals make progress in Asia as Japan issues emergency approval to Merck's Lagevrio in a matter of weeks and South Korea clears Pfizer's contender Paxlovid. Vaccines also move forward in both countries with deals for boosters, new supply agreements and the advancement of home-grown candidates.
